AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 565.05 Change Price %
High 596.65 1 Day 15.85 2.78
Low 561.00 1 Week -5.70 -0.96
Close 586.85 1 Month -53.95 -8.42
Volume 6761246 1 Year -91.35 -13.47
52 Week High 809.45
52 Week Low 503.05
AUROPHARMA Important Levels
Resistance 2 619.90
Resistance 1 606.28
Pivot 581.50
Support 1 567.42
Support 2 553.80
NSE INDIA Most Active Stocks
SUZLON 12.55 -2.71%
RCOM 27.35 -2.32%
GMRINFRA 17.55 1.45%
PNB 114.60 -2.30%
IDBI 74.10 5.41%
ESL 3.45 4.55%
ESL 3.45 4.55%
ESL 3.45 4.55%
ESL 3.45 4.55%
JPASSOCIAT 16.35 -1.80%
More..
NSE INDIA Top Gainers Stocks
TARAJEWELS 14.90 19.68%
WINDMACHIN 120.35 17.36%
APOLLO 321.25 14.18%
FCSSOFT 0.45 12.50%
SREEL 249.60 11.21%
PGEL 322.65 10.61%
EIHAHOTELS 574.50 10.57%
KANANIIND 10.10 8.02%
MAHASTEEL 81.30 7.97%
MANAKCOAT 17.15 7.86%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.25 -16.67%
GSS 47.15 -6.82%
GSS 47.15 -6.82%
GSS 47.15 -6.82%
GSS 47.15 -6.82%
RAJVIR 44.05 -6.67%
PDUMJEIND 14.60 -6.11%
FORTIS 146.30 -5.92%
PANAMAPET 179.90 -5.84%
PCJEWELLER 327.50 -5.35%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 4
As on 22nd Feb 2018 AUROPHARMA Share Price closed @ 586.85 and we RECOMMEND Sell for LONG-TERM with Stoploss of 678.89 & Strong Sell for SHORT-TERM with Stoploss of 647.18 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for February
1st Target up-side 670.86
2nd Target up-side 699.82
3rd Target up-side 728.77
1st Target down-side 588.24
2nd Target down-side 559.28
3rd Target down-side 530.33
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 38.73 Sideways
MFI (14) MFI is 34.17 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is -62.99 Sideways
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 610.68
10 Day Avg Volume Traded 104.87 % More then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.